GLOBALFOUNDRIES has retreated from its May highs — the stock closed at $84.60 on June 2, down roughly 6% on the week — yet the broader setup remains more orderly than the price action implies.
The key tension this week is valuation versus conviction. A month ago the stock was trading in the mid-$60s. It ran to nearly $90, the Street scrambled to reprice, and now GFS has drifted back below most of the targets that were just raised. The question is whether this is consolidation after a historic re-rating, or the beginning of a more uncomfortable reassessment.
Short positioning tells a calm story. Short interest has fallen sharply — down roughly 25% over the past month to 1.7% of the free float. That's a low absolute level, and the direction of travel makes it hard to read as a bearish signal. Borrow costs reinforce that reading: the cost to borrow is just 0.45%, barely above the floor, with no signs of stress. Availability is extremely loose at roughly 960% — meaning there are nearly ten times as many shares available to borrow as there are currently borrowed. The lending market is sending no warning signal whatsoever. The ORTEX short score has also dropped, from around 53 a week ago to 44.4 — a meaningful move that reflects the unwinding of short exposure alongside the broader re-rating.
Options positioning has shifted modestly more cautious. The put/call ratio is running at 0.71, a touch above its 20-day average of 0.64, though the z-score of 0.51 is well within normal range. This is not a market bracing for a crash — it's a market hedging into a stock that has already moved a lot. The 52-week PCR range runs from 0.09 to 2.33, which puts the current reading firmly in neutral territory.
The Street angle is where the real tension lives. Most analysts lifted targets aggressively after the Q1 earnings beat on May 5, yet the consensus mean of roughly $79 now sits below where the stock trades at $84.60. JP Morgan, Citigroup, and Morgan Stanley — all neutral — have targets in the $65-$77 range. Susquehanna's bull case reaches $125. Evercore ISI's Mark Lipacis carried an $85 Outperform target as of May 19. The distribution is wide, and the stock has now moved through the midpoint of that range. The factor picture adds nuance: the analyst recommendation divergence rank is at the 99th percentile, meaning the gap between bulls and bears on GFS is wider than almost any stock in the universe. Valuation has re-rated sharply — the P/E has expanded by more than 5 points over 30 days to nearly 39x, and price-to-book has climbed 0.75 points to 3.7x — reflecting how much of the earnings re-rating has already been priced in. The bull case rests on geopolitical tailwinds, AI-adjacent demand, and a domestic manufacturing edge. The bear case centres on mature-node dependency, customer concentration, and limited margin headroom.
Institutional ownership adds important context. Mubadala, the Abu Dhabi sovereign fund, controls 77% of the company — a concentration that limits the freely traded float and can amplify both up and down moves. FMR (Fidelity) holds a further 11.6% and added 8.5 million shares in Q1. Among the active managers, Marshall Wace added 2.7 million shares in the same period. Insider activity over the past month has been entirely sales — small, regular transactions from the Chief Legal Officer and other executives, all with low significance scores — consistent with routine share-plan selling rather than any directional view.
The week's peer moves frame the pullback in context. Close correlated names had a strong Tuesday: ON Semiconductor gained 6.4% on the day and Lattice Semiconductor was up 4.6%, suggesting sector sentiment is broadly supportive even as GFS gave back ground on the week. With the next earnings event not until August 4, the stock now has a two-month runway in which the valuation debate — and the gap between the most bullish and most cautious targets on the Street — will need to find its own equilibrium.
See the live data behind this article on ORTEX.
Open GFS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
